ESR1 and breast carcinoma: Induction with E2 (10−9M) significantly (p < 0.01) decreased ER+ breast cancer cell migration (Figures 4A,B), while 4-OH-Tam and SM6Met alone both counteracted the inhibitory effects of E2, by significantly increasing cell motility.